Tissue-based next generation sequencing: application in a universal healthcare system.

https://phgkb.cdc.gov/GAPPKB/phgHome.do




Last Posted: Jun 01, 2017

---

• Tissue-based next generation sequencing: application in a universal healthcare system.  
  Hynes Seán O et al. British journal of cancer 2017 Feb 116(5) 553-560
• Decisions on Further Research for Predictive Biomarkers of High-Dose Alkylating Chemotherapy in Triple-Negative Breast Cancer: A Value of Information Analysis.  
  Miquel-Cases Anna et al. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2016 Jun 19(4) 419-30
• Precision Medicine-Nobody Is Average.  
  Vinks A A et al. Clinical pharmacology and therapeutics 2017 Mar 101(3) 304-307
• The Use of Economic Evaluation to Inform Newborn Screening Policy Decisions: The Washington State Experience.  
  Grosse Scott D et al. The Milbank quarterly 2016 Jun 94(2) 366-91
• A Cost-Effectiveness Evaluation of Germline BRCA1 and BRCA2 Testing in UK Women with Ovarian Cancer.  
  Eccleston Anthony et al. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2017 Apr 20(4) 567-576
• A Multigene Test Could Cost-Effectively Help Extend Life Expectancy for Women at Risk of Hereditary Breast Cancer.  
  Li Yonghong et al. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2017 Apr 20(4) 547-555
• International Developments in the Care of Familial Hypercholesterolemia: Where Now and Where to Next?  
  Pang Jing et al. Journal of atherosclerosis and thrombosis 2016 May 23(5) 505-19
• Cost-effectiveness of different strategies to prevent breast and ovarian cancer in German women with a BRCA 1 or 2 mutation.  
  Müller Dirk et al. The European journal of health economics : HEPAC : health economics in prevention and care 2017 Apr
• Economic Evaluations of Thrombophilia Screening Prior to Prescribing Combined Oral Contraceptives: A Systematic and Critical Review.  
  Vernon Erin et al. Applied health economics and health policy 2017 Mar
• How economics can shape precision medicines  
  AD Stern et al, Science, March 17, 2017
• Evolving Trends and Influencing Factors in Mastectomy Decisions.  
  Bhat Sneha et al. The American surgeon 2017 Mar 83(3) 233-238
• Decision Making on Medical Innovations in a Changing Health Care Environment: Insights from Accountable Care Organizations and Payers on Personalized Medicine and Other Technologies.  
  Trosman Julia R et al. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2017 Jan 20(1) 40-46
• Preferences regarding contemporary prenatal genetic tests among women desiring testing: implications for optimal testing strategies.  
  Kuppermann Miriam et al. Prenatal diagnosis 2016 May 36(5) 469-75
• Personalized medicine for prevention: can risk stratified screening decrease colorectal cancer mortality at an acceptable cost?  
  Subramanian Sujha et al. Cancer causes & control : CCC 2017 Feb
• "What Goes Around Comes Around": Lessons Learned from Economic Evaluations of Personalized Medicine Applied to Digital Medicine.  
  Phillips Kathryn A et al. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2017 Jan 20(1) 47-53
• Cost-effectiveness of risk-reducing surgeries in preventing hereditary breast and ovarian cancer.  
  Schrauder Michael G et al. Breast (Edinburgh, Scotland) 2017 Feb 32186-191

more